These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27346574)

  • 1. CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas.
    Pascual-García M; Bértolo C; Nieto JC; Serrat N; Espinosa Í; D'Angelo E; Muñoz R; Rovira R; Vidal S; Prat J
    Hum Pathol; 2016 Oct; 56():180-8. PubMed ID: 27346574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
    Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
    Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma.
    Kondratiev S; Sabo E; Yakirevich E; Lavie O; Resnick MB
    Clin Cancer Res; 2004 Jul; 10(13):4450-6. PubMed ID: 15240536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes.
    Crumley S; Kurnit K; Hudgens C; Fellman B; Tetzlaff MT; Broaddus R
    Mod Pathol; 2019 Mar; 32(3):396-404. PubMed ID: 30291344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.
    Miyatake T; Tringler B; Liu W; Liu SH; Papkoff J; Enomoto T; Torkko KC; Dehn DL; Swisher A; Shroyer KR
    Gynecol Oncol; 2007 Jul; 106(1):119-27. PubMed ID: 17509674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas.
    Vagios S; Yiannou P; Giannikaki E; Doulgeraki T; Papadimitriou C; Rodolakis A; Nonni A; Vlachos A; Pavlakis K
    Int J Clin Oncol; 2019 Nov; 24(11):1419-1428. PubMed ID: 31197557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.
    Ikeda Y; Kiyotani K; Yew PY; Sato S; Imai Y; Yamaguchi R; Miyano S; Fujiwara K; Hasegawa K; Nakamura Y
    Oncol Rep; 2017 May; 37(5):2603-2610. PubMed ID: 28358435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages.
    Kono-Sato T; Miyai K; Yamagishi Y; Miyamoto M; Takano M; Matsukuma S; Sato K; Tsuda H
    BMC Cancer; 2022 Apr; 22(1):361. PubMed ID: 35366828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
    Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
    Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zone Formation of Lymphocyte Infiltration at Invasive Front as a Biomarker of Prognosis in Endometrial Carcinomas.
    Miyamoto M; Takano M; Tsuda H; Matuura H; Aoyama T; Soyama H; Kato K; Iwahashi H; Ishibashi H; Yoshikawa T; Suzuki A; Hirata J; Furuya K
    Oncology; 2019; 96(2):93-100. PubMed ID: 30282081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial Cancer Suppresses CD8+ T Cell-Mediated Cytotoxicity in Postmenopausal Women.
    Patel MV; Shen Z; Rodriguez-Garcia M; Usherwood EJ; Tafe LJ; Wira CR
    Front Immunol; 2021; 12():657326. PubMed ID: 33968059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations.
    Willvonseder B; Stögbauer F; Steiger K; Jesinghaus M; Kuhn PH; Brambs C; Engel J; Bronger H; Schmidt GP; Haller B; Weichert W; Keller G; Noske A; Pfarr N; Boxberg M
    Cancer Immunol Immunother; 2021 Jun; 70(6):1679-1689. PubMed ID: 33340331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
    Versluis MAC; Marchal S; Plat A; de Bock GH; van Hall T; de Bruyn M; Hollema H; Nijman HW
    Eur J Cancer; 2017 Nov; 86():285-295. PubMed ID: 29059634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer.
    Iurchenko NP; Glushchenko NM; Buchynska LG
    Exp Oncol; 2014 Dec; 36(4):262-6. PubMed ID: 25537221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody.
    Bignotti E; Ravaggi A; Romani C; Falchetti M; Lonardi S; Facchetti F; Pecorelli S; Varughese J; Cocco E; Bellone S; Schwartz PE; Rutherford TJ; Santin AD
    Int J Gynecol Cancer; 2011 Dec; 21(9):1613-21. PubMed ID: 21892093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.